Epigenetic and transcriptional regulation of IRAK-M expression in macrophages

Journal of Immunology

Volumn 198, Issue 3, 2017, Pages 1297-1307

  Lyroni, Konstantina ^a   Patsalos, Andreas ^a,c   Daskalaki, Maria G ^a   Doxaki, Christina ^a   Soennichsen, Birte ^b,d   Helms, Mike ^b,e   Liapis, Ioannis ^a   Zacharioudaki, Vassiliki ^a   Kampranis, Sotirios C ^a   Tsatsanis, Christos ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b Cenix BioScience GmbH   (Germany)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d Life Science Inkubator Dresden   (Germany)

^e SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE 3 LYSINE 27; HISTONE H3; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; LIPOPOLYSACCHARIDE; POLYCOMB REPRESSIVE COMPLEX 2; TETRATRICOPEPTIDE REPEAT PROTEIN; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG; CCAAT ENHANCER BINDING PROTEIN BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK3 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME MECHANISM; ENZYME REPRESSION; EPIGENETICS; LIMIT OF QUANTITATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; X CHROMOSOME; ANIMAL; CELL CULTURE; DEALKYLATION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; MACROPHAGE; METABOLISM; PHYSIOLOGY;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELLS, CULTURED; DEALKYLATION; EPIGENESIS, GENETIC; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 85014648257     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600009     Document Type: Article

References (56)

1. Medzhitov, R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819-826.
2. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
3. Kawai, T., and S. Akira. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11: 373-384.
4. Janssens, S., and R. Beyaert. 2003. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell 11: 293-302.
5. Kobayashi, K., L. D. Hernandez, J. E. Galán, C. A. Janeway, Jr., R. Medzhitov, and R. A. Flavell. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202.
6. Seki, M., S. Kohno, M. W. Newstead, X. Zeng, U. Bhan, N. W. Lukacs, S. L. Kunkel, and T. J. Standiford. 2010. Critical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia. J. Immunol. 184: 1410-1418.
7. Hoogerwerf, J. J., G. J. van der Windt, D. C. Blok, A. J. Hoogendijk, A. F. De Vos, C. van 't Veer, S. Florquin, K. S. Kobayashi, R. A. Flavell, and T. van der Poll. 2012. Interleukin-1 receptor-associated kinase M-deficient mice demonstrate an improved host defense during Gram-negative pneumonia. Mol. Med. 18: 1067-1075.
8. van der Windt, G. J., D. C. Blok, J. J. Hoogerwerf, A. J. Lammers, A. F. de Vos, C. Van't Veer, S. Florquin, K. S. Kobayashi, R. A. Flavell, and T. van der Poll. 2012. Interleukin 1 receptor-associated kinase M impairs host defense during pneumococcal pneumonia. J. Infect. Dis. 205: 1849-1857.
9. Lech, M., C. Kantner, O. P. Kulkarni, M. Ryu, E. Vlasova, J. Heesemann, D. Anz, S. Endres, K. S. Kobayashi, R. A. Flavell, et al. 2011. Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus. Ann. Rheum. Dis. 70: 2207-2217.
10. Tan, Q., M. Majewska-Szczepanik, X. Zhang, M. Szczepanik, Z. Zhou, F. S. Wong, and L. Wen. 2014. IRAK-M deficiency promotes the development of type 1 diabetes in NOD mice. Diabetes 63: 2761-2775.
11. Hulsmans, M., B. Geeraert, T. Arnould, C. Tsatsanis, and P. Holvoet. 2013. PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression. PLoS One 8: e62253.
12. Hulsmans, M., B. Geeraert, D. De Keyzer, A. Mertens, M. Lannoo, B. Vanaudenaerde, M. Hoylaerts, N. Benhabilès, C. Tsatsanis, C. Mathieu, and P. Holvoet. 2012. Interleukin-1 receptor-associated kinase-3 is a key inhibitor of inflammation in obesity and metabolic syndrome. PLoS One 7: e30414.
13. Zacharioudaki, V., A. Androulidaki, A. Arranz, G. Vrentzos, A. N. Margioris, and C. Tsatsanis. 2009. Adiponectin promotes endotoxin tolerance in macrophages by inducing IRAK-M expression. J. Immunol. 182: 6444-6451.
14. Kim, Y. I., J. E. Park, K. H. Kwon, C. Y. Hong, and A. K. Yi. 2012. Interleukin-1 receptor-associated kinase 2- and protein kinase D1-dependent regulation of IRAK-monocyte expression by CpG DNA. PLoS One 7: e43970.
15. Lee, T. I., and R. A. Young. 2013. Transcriptional regulation and its misregulation in disease. Cell 152: 1237-1251.
16. Natoli, G. 2010. Maintaining cell identity through global control of genomic organization. Immunity 33: 12-24.
17. Cao, R., L. Wang, H. Wang, L. Xia, H. Erdjument-Bromage, P. Tempst, R. S. Jones, and Y. Zhang. 2002. Role of histone H3 lysine 27 methylation in polycomb-group silencing. Science 298: 1039-1043.
18. Hong, S., Y. W. Cho, L. R. Yu, H. Yu, T. D. Veenstra, and K. Ge. 2007. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proc. Natl. Acad. Sci. USA 104: 18439-18444.
19. Agger, K., P. A. Cloos, J. Christensen, D. Pasini, S. Rose, J. Rappsilber, I. Issaeva, E. Canaani, A. E. Salcini, and K. Helin. 2007. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449: 731-734.
20. Lee, M. G., R. Villa, P. Trojer, J. Norman, K. P. Yan, D. Reinberg, L. Di Croce, and R. Shiekhattar. 2007. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 318: 447-450.
21. Seenundun, S., S. Rampalli, Q. C. Liu, A. Aziz, C. Palii, S. Hong, A. Blais, M. Brand, K. Ge, and F. J. Dilworth. 2010. UTX mediates demethylation of H3K27me3 at muscle-specific genes during myogenesis. EMBO J. 29: 1401-1411.
22. Medzhitov, R., and T. Horng. 2009. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 9: 692-703.
23. Foster, S. L., D. C. Hargreaves, and R. Medzhitov. 2007. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978.
24. Byrd, R. A., S. D. Sorden, T. Ryan, T. Pienkowski, R. LaRock, R. Quander, J. A. Wijsman, H. W. Smith, J. L. Blackbourne, T. J. Rosol, et al. 2015. Chronic toxicity and carcinogenicity studies of the long-acting GLP-1 receptor agonist dulaglutide in rodents. Endocrinology 156: 2417-2428.
25. Guo, H., N. Diao, R. Yuan, K. Chen, S. Geng, M. Li, and L. Li. 2016. Subclinical-dose endotoxin sustains low-grade inflammation and exacerbates steatohepatitis in high-fat diet-fed mice. J. Immunol. 196: 2300-2308.
26. Netea, M. G. 2013. Training innate immunity: the changing concept of immunological memory in innate host defence. Eur. J. Clin. Invest. 43: 881-884.
27. Tanaka, T., S. Akira, K. Yoshida, M. Umemoto, Y. Yoneda, N. Shirafuji, H. Fujiwara, S. Suematsu, N. Yoshida, and T. Kishimoto. 1995. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80: 353-361.
28. Ruffell, D., F. Mourkioti, A. Gambardella, P. Kirstetter, R. G. Lopez, N. Rosenthal, and C. Nerlov. 2009. A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc. Natl. Acad. Sci. USA 106: 17475-17480.
29. Lu, Y. C., I. Kim, E. Lye, F. Shen, N. Suzuki, S. Suzuki, S. Gerondakis, S. Akira, S. L. Gaffen, W. C. Yeh, and P. S. Ohashi. 2009. Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines. J. Immunol. 182: 7212-7221.
30. Doxaki, C., S. C. Kampranis, A. G. Eliopoulos, C. Spilianakis, and C. Tsatsanis. 2015. Coordinated regulation of miR-155 and miR-146a genes during induction of endotoxin tolerance in macrophages. J. Immunol. 195: 5750-5761.
31. Landschulz, W. H., P. F. Johnson, and S. L. McKnight. 1989. The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite. Science 243: 1681-1688.
32. El Gazzar, M., T. Liu, B. K. Yoza, and C. E. McCall. 2010. Dynamic and selective nucleosome repositioning during endotoxin tolerance. J. Biol. Chem. 285: 1259-1271.
33. El Gazzar, M., B. K. Yoza, J. Y. Hu, S. L. Cousart, and C. E. McCall. 2007. Epigenetic silencing of tumor necrosis factor alpha during endotoxin tolerance. J. Biol. Chem. 282: 26857-26864.
34. Pan, H., E. Ding, M. Hu, A. S. Lagoo, M. B. Datto, and S. A. Lagoo-Deenadayalan. 2010. SMAD4 is required for development of maximal endotoxin tolerance. J. Immunol. 184: 5502-5509.
35. Wu, Y., C. Lan, D. Ren, and G. Y. Chen. 2016. Induction of Siglec-1 by endotoxin tolerance suppresses the innate immune response by promoting TGF-β1 production. J. Biol. Chem. 291: 12370-12382.
36. Margueron, R., and D. Reinberg. 2011. The polycomb complex PRC2 and its mark in life. Nature 469: 343-349.
37. Müller, J., and P. Verrijzer. 2009. Biochemical mechanisms of gene regulation by polycomb group protein complexes. Curr. Opin. Genet. Dev. 19: 150-158.
38. Wu, Q., D. Jiang, S. Smith, J. Thaikoottathil, R. J. Martin, R. P. Bowler, and H. W. Chu. 2012. IL-13 dampens human airway epithelial innate immunity through induction of IL-1 receptor-associated kinase M. J. Allergy Clin. Immunol. 129: 825-833 e822.
39. Lai, T. Y., S. D. Wu, M. H. Tsai, E. Y. Chuang, L. L. Chuang, L. C. Hsu, and L. C. Lai. 2013. Transcription of Tnfaip3 is regulated by NF-κB and p38 via C/EBPβ in activated macrophages. PLoS One 8: e73153.
40. Marigo, I., E. Bosio, S. Solito, C. Mesa, A. Fernandez, L. Dolcetti, S. Ugel, N. Sonda, S. Bicciato, E. Falisi, et al. 2010. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 32: 790-802.
41. Ye, S., H. Xu, J. Jin, M. Yang, C. Wang, Y. Yu, and X. Cao. 2012. The E3 ubiquitin ligase neuregulin receptor degradation protein 1 (Nrdp1) promotes M2 macrophage polarization by ubiquitinating and activating transcription factor CCAAT/enhancer-binding protein β (C/EBPβ). J. Biol. Chem. 287: 26740-26748.
42. Vergadi, E., K. Vaporidi, E. E. Theodorakis, C. Doxaki, E. Lagoudaki, E. Ieronymaki, V. I. Alexaki, M. Helms, E. Kondili, B. Soennichsen, et al. 2014. Akt2 deficiency protects from acute lung injury via alternative macrophage activation and miR-146a induction in mice. J. Immunol. 192: 394-406.
43. van 't Veer, C., P. S. van den Pangaart, M. A. van Zoelen, M. de Kruif, R. S. Birjmohun, E. S. Stroes, A. F. de Vos, and T. van der Poll. 2007. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J. Immunol. 179: 7110-7120.
44. Kim, W., G. H. Bird, T. Neff, G. Guo, M. A. Kerenyi, L. D. Walensky, and S. H. Orkin. 2013. Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer. Nat. Chem. Biol. 9: 643-650.
45. Herrera-Merchan, A., L. Arranz, J. M. Ligos, A. de Molina, O. Dominguez, and S. Gonzalez. 2012. Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease. Nat. Commun. 3: 623.
46. Kruidenier, L., C. W. Chung, Z. Cheng, J. Liddle, K. Che, G. Joberty, M. Bantscheff, C. Bountra, A. Bridges, H. Diallo, et al. 2012. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 488: 404-408.
47. Kuzmichev, A., T. Jenuwein, P. Tempst, and D. Reinberg. 2004. Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol. Cell 14: 183-193.
48. McCall, C. E., B. Yoza, T. Liu, and M. El Gazzar. 2010. Gene-specific epigenetic regulation in serious infections with systemic inflammation. J. Innate Immun. 2: 395-405.
49. Sullivan, K. E., A. B. Reddy, K. Dietzmann, A. R. Suriano, V. P. Kocieda, M. Stewart, and M. Bhatia. 2007. Epigenetic regulation of tumor necrosis factor alpha. Mol. Cell. Biol. 27: 5147-5160.
50. Chow, N. A., L. D. Jasenosky, and A. E. Goldfeld. 2014. A distal locus element mediates IFN-γ priming of lipopolysaccharide-stimulated TNF gene expression. Cell Rep. 9: 1718-1728.
51. Liu, T. F., B. K. Yoza, M. El Gazzar, V. T. Vachharajani, and C. E. McCall. 2011. NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance. J. Biol. Chem. 286: 9856-9864.
52. Vachharajani, V., T. Liu, and C. E. McCall. 2014. Epigenetic coordination of acute systemic inflammation: potential therapeutic targets. Expert Rev. Clin. Immunol. 10: 1141-1150.
53. Vachharajani, V. T., T. Liu, X. Wang, J. J. Hoth, B. K. Yoza, and C. E. McCall. 2016. Sirtuins link inflammation and metabolism. J. Immunol. Res. 2016: 8167273.
54. Chan, C., L. Li, C. E. McCall, and B. K. Yoza. 2005. Endotoxin tolerance disrupts chromatin remodeling and NF-kappaB transactivation at the IL-1beta promoter. J. Immunol. 175: 461-468.
55. Yoza, B. K., and C. E. McCall. 2011. Facultative heterochromatin formation at the IL-1 beta promoter in LPS tolerance and sepsis. Cytokine 53: 145-152.
56. Lee, T. I., R. G. Jenner, L. A. Boyer, M. G. Guenther, S. S. Levine, R. M. Kumar, B. Chevalier, S. E. Johnstone, M. F. Cole, K. Isono, et al. 2006. Control of developmental regulators by polycomb in human embryonic stem cells. Cell 125: 301-313.